Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.
Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.
Active, not recruiting · NCT06506955 · Registry updated 2026-07-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy. | Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, adenocarcinoma, carcinoma, cholangiocarcinoma, epithelial neoplasm, neoplasm | Active, not recruiting | Phase 2 / Phase 3 | 2026-07-28 | NCT06506955 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Taiho Oncology, Inc. | 24 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centro Integral Oncologico | Madrid | Spain | 1 |
| Hospital Universitari, Vall d'Hebron | Barcelona | Spain | 1 |
| Institut De Cancerologie Strasbourg | Strasbourg | France | 1 |
| Institut Paoli-Calmettes | Marseille | France | 35 |
| Royal Marsden NHS Foundation Trust | London | United Kingdom | 11 |
| Sarah Cannon Research Institute UK | London | United Kingdom | 26 |
| Severance Hospital | Seoul | South Korea | 5 |
| University College London Hospitals NHS Foundation Trust | London | United Kingdom | 8 |
| University of California, San Francisco (UCSF) | San Francisco | United States | 12 |